Press release Mujinga Kambundji
PDF | 386.79 KB
Hirslanden further expands its involvement with Mujinga Kambundji, which has been in existence for two years. This gives her access to the nationwide Hirslanden sports medicine network.
The Hirslanden Group considers sports medicine to be one of its core fields of expertise and is further expanding this medical specialty through attractive partnerships and new, partly digital offers. Hirslanden’s association with Mujinga Kambundji represents a further major involvement in sports medicine for the Group following the announcement of the cooperation with Swiss-Ski in May (To the press release «Hirslanden new official medical partner of Swiss-Ski»).
Sportsmen and women as well as sports enthusiasts receive continuous guidance and care in the fields of prevention, coaching, therapeutic approaches or treatment for acute medical conditions. "We have great expertise in the care of athletes from the professional and junior sectors," says Daniel Liedtke, CEO of the Hirslanden Group. "As a result, our sports medicine departments always have the latest findings and trends at their disposal, from which sports enthusiasts from the amateur sector and mass sports benefit equally."
Thanks to the partnership with Hirslanden, Mujinga Kambundji benefits from specific performance diagnostics, close support from her doctor and, in the event of an injury, «Fast track access» to all diagnostic examinations in one of the best-equipped Hirslanden hospitals. In the case of her torn ligament in 2019, for example, Mujinga was able to return to full training just a few weeks after her accident thanks to targeted measures and close medical supervision. A few months later, she won bronze at the 2019 World Championships in Doha. Mujinga reports on how this was possible during an interview and gives insights into her training programme despite her injury and the treatment methods that got her back on track so quickly (to the video).
Mujinga was born in Bern on 17 June 1992. Her mother Ruth comes from the Bernese Oberland, where she grew up on the family farm and where her grandmother still lives to this day. Mujinga’s father, Safuka, is of Congolese descent.
She had her breakthrough at the Home European Championships in Zurich in 2014, where she attracted attention through her exceptional results and her warm smile. Her biggest achievement is the bronze medal in the 200m at the 2019 World Championships in Doha. Before that, she won a bronze medal at the 2016 European Championships and the 2018 World Indoor Championships. At the Olympic Games in Tokyo this summer, Mujinga made history. Kambundji qualified for the finals in all three of her events and set at least one Swiss record in each.
The Hirslanden Group operates 17 hospitals in 10 cantons, many of which have an emergency department. It also operates 4 outpatient surgical units, 17 radiology institutes and 5 radiotherapy institutes. Together with public and private cooperation partners, Hirslanden focuses on the continuum of care and promoting high-quality, responsible, personalised and efficiently integrated healthcare – this explicitly includes, especially in the current situation, prevention in addition to acute treatment in hospitals.
The Hirslanden Group has 2 314 partner doctors and 10 711 employees, 479 of whom are permanently employed doctors. Hirslanden is the largest medical network in Switzerland. In the 2020/21 financial year, the Group generated turnover of CHF 1 796 million (incl. CHF 12.6 Mio. cantonal COVID-19 compensations). As at 31.3.2021, the Group had treated 107 401 patients, amounting to a total of 461 004 inpatient days. In insurance terms, the patient mix consists of 51% basic, 28.8% semi-private, and 20.2% private insured patients.
Hirslanden is synonymous with first-class medical care provided by highly qualified medical specialists with many years of experience. As a system provider, the Group stands out from the rest of the market: interdisciplinary medical centres of expertise and specialised institutes enable it to offer the best possible individualised treatment, even in highly complex cases. The Hirslanden Group was formed in 1990 through the merger of several hospitals. Since 2007, it has been part of the international hospital group Mediclinic International plc, which is listed on the London Stock Exchange.